Creating synthetic structures to improve cell function and treat diseases.
Development of functional synthetic biomolecular condensates.
This study is exploring how to create artificial structures in our cells that help keep everything organized, which could lead to new treatments for diseases like cancer and brain disorders by fixing problems with how proteins work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia Univ New York Morningside NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10913462 on NIH RePORTER |
What this research studies
This research focuses on developing synthetic biomolecular condensates, which are specialized structures within cells that help organize cellular functions such as signaling and gene expression. By understanding how these structures form and operate, researchers aim to address diseases linked to dysfunctional protein condensates, including certain cancers and neurodegenerative disorders. The approach involves studying the interactions between proteins and their environment to create effective synthetic versions that can mimic natural processes. Patients may benefit from new treatment strategies that target the underlying mechanisms of their conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with cancers or neurodegenerative diseases linked to protein condensate dysfunction.
Not a fit: Patients with conditions unrelated to cellular function or protein condensate dysregulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies for diseases caused by dysfunctional cellular processes.
How similar studies have performed: While the concept of biomolecular condensates is established, the development of synthetic versions is a novel approach that has not been extensively tested.
Where this research is happening
New York, United States
- Columbia Univ New York Morningside — New York, United States (Active)
Researchers
- Principal investigator: Obermeyer, Allie C — Columbia Univ New York Morningside
- Study coordinator: Obermeyer, Allie C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.